The maternal immune system in health and disease

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 6, 1998, Pages 453-458

  Iwatani, Yoshinori ^a   Watanabe, Mikio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; DECIDUA; HELPER CELL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; TROPHOBLAST;

AUTOIMMUNE DISEASES; DECIDUA; FEMALE; HUMANS; LYMPHOCYTES; PREGNANCY; PREGNANCY COMPLICATIONS; TROPHOBLASTS;

EID: 0032421627     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199812000-00004     Document Type: Review

References (50)

1. Lenfant F, Fort M, Rodriguez AM, Campan A, Aguerre-Girr M, Sommer E, • et al. Absence of imprinting of HLA class Ia genes leads to co-expression of biparental alleles on term human trophoblast cells upon IFN-γ induction. Immunogenetics 1998; 47:297-304. A clear-cut study demonstrating that the repressed expression of HLA class Ia gene and protein in trophoblast cells can be reversed by IFN-γ stimulation.
2. Gustafsson E, Arvola M, Brunsverg U, Mattsson A, Mattsson R. Lack of detectable major histocompatibility complex class IIa beta-chain messenger ribonucleic acid in placentas of interferon-γ- and 5-azacytidine-treated mice. Biol Reprod 1997; 57:715-722.
3. Labarrere CA, Faulk WP. MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology. Transplantation 1990; 50:812-816.
4. Ober C, Hyslop T, Elias S, Weitkamp LR, Hauck WW. Human leukocyte • antigen matching and fetal loss: result of a 10 year prospective study. Hum Reprod 1998; 13:33-38. A well-designed study showing evidence that matching for the entire 16-locus haplotype or alleles at an HLA-B-linked locus confers a significant risk for fetal loss.
5. Münz C, Holmes N, King A, Loke YW, Colonna M, Schild H, Rammensee HG. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997; 185:385-391.
6. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a •• thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997; 186:289-298. This study demonstrated clearly for the first time that HLA-G molecules, whose expression is primarily restricted to the extravillous trophoblast, are also expressed on thymic medullary and subcapsular epithelial cells.
7. Maejima M, Fujii T, Kozuma S, Okai T, Shibata Y, Taketani Y. Presence of • HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines. Am J Reprod Immunol 1997; 38:79-82. This is the first study examining the effect of HLA-G molecules on the ability of mononuclear cells other than NK activity.
8. Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody '87G' and anti-cytokeratin antibody 'CAM5.2'. Am J Reprod Immunol 1996; 36:349-358.
9. Iaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, • et al. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997; 27:3380-3388. This group of researchers continue to lead the field in studying the expression of MHC class Ia and Ib in placenta. Here they report that HLA-G is also expressed in endothelial cells in chorionic fetal vessels, in which endothelial mitoses are reported.
10. Uckan D, Steele A, Cherry , Wang BY, Chamizo W, Koutsonikolis A, et al. •• Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997; 3:655-662. This is the first report on Fas ligand expression on trophoblast, contributing to immune privilege in this unique environment.
11. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa • SL. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997; 82:3173-3175. The same as in Reference [10••].
12. Runic R, Lockwood CJ, Lachapelle L, Dipasquale B, Demopoulos RI, • Kumar A, Guller S. Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab 1998; 83:660-666. A study based on biochemical and morphological parameters, reporting that apoptosis is a physiological process in human fetal membranes in the third trimester of pregnancy.
13. Rand JH, Wu X, Andree HAM, Lockwood CJ, Guller S, Scher J, Harpel •• PC. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337:154-160. This group leads the field in understanding of the role played by annexin V on trophoblast. Here they clarified an antithrombotic role for annexin V and a possible mechanism of thrombosis and pregnancy loss in the antiphospholipid-antibody syndrome.
14. Svinarich DM, Gomez R, Romero R. Detection of human defensins in the placenta. Am J Reprod Immunol 1997; 38:252-255.
15. Paulesu L, Romagnoli R, Fortino V, Cintorino M, Bischof P. Distribution of type-I interferon-receptors in human first trimester and term placental tissues and on isolated trophoblast cells. Am J Reprod Immunol 1997; 37:443-448.
16. Olding LB, Papadogiannakis N, Barbieri B, Murgita RA. Suppressive cellular and molecular activities in maternofetal immune interactions; suppressor cell activity, prostaglandins, and α-fetoproteins. Curr Top Microbiol Immunol 1997; 222:159-187.
17. Hunt JS, Miller L, Roby KF, Huang J, Platt JS, DeBrot BL. Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes. J Reprod Immunol 1997; 35:87-99.
18. Aarli A, Kristoffersen EK, Jensen TS, Ulvestad E, Matre R. Suppressive effect on lymphoproliferation in vitro by soluble Annexin II released from isolated placental membranes. Am J Reprod Immunol 1997; 38:313-319.
19. Wang H, Zhang M, Soda K, Sama A, Tracey KJ. Fetuin protects the fetus from TNF. Lancet 1997; 350:861-862.
20. + lymphocytes in an in vitro culture system. J Clin Endocrinol Metab 1996; 81:1502-1507.
21. - peripheral blood and decidual granular lymphocyte-derived clones. Am J Reprod Immunol 1997; 38:162-167.
22. Hiby SE, King A, Sharkey AM, Loke YW. Human uterine NK cells have a •• similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Mol Immunol 1997; 34:419-430. This research group continues to lead the field in understanding of the role played by uterine NK cells in pregnancy. Here they provided for the first time clear molecular evidence for the potential for direct interaction between decidual maternal NK cells and infiltrating fetally derived trophoblast via NK receptor/HLA recognition.
23. Rouas-Freiss N, Gonçalves MB, Menier C, Dausset J, Carosella ED. •• Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94:11520-11525. The same as Reference [22••].
24. Guimond MJ, Wang B, Cray BA. Engraftment of bone marrow from •• severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient trε26 mice. J Exp Med 1998; 187:217-223. This research group also leads the study on uterine NK cells, and they demonstrated that uterine NK cells are essential for the establishment and maintenance of pregnancy.
25. Jokhi PP, King A, Loke YW. Production of granulocyte-macrophage colony-stimulating factor by human trophoblast cells and by decidual large granular lymphocytes. Hum Reprod 1994; 9:1660-1669.
26. Mincheva-Nilsson E, Kling M, Hammarström S, Nagaeva O, Sundqvist •• KG, Hammarström ML, Baranov V. γδ T cells of human early pregnancy decidua: evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol 1997; 159:3266-3277. This study explained the heterogeneity of the surface phenotype of γδ T cells and their local proliferation by the existence of an extrathymic pathway for γδ T cell differentiation in the human early pregnancy decidua.
27. Suzuki T, Hiromatsu K, Ando Y, Okamoto T, Tomoda Y, Yoshikai Y. Regulatory role of γδ T cells in uterine intraepithelial lymphocytes in maternal antifetal immune response. J Immunol 1995; 154:4476-4484.
28. Jiang SP, Vacchio MS. Multiple mechanisms of peripheral T cell tolerance •• to the fetal 'Allograft'. J Immunol 1998; 160:3086-3090. A clear-cut study, using H-Y-specific TCR transgenic mice, demonstrated that the specific recognition of fetal alloantigens by maternal T cells results in tolerance induction of reactive T cells via multiple mechanisms.
29. Kelly RW, Critchley HO. T-cell modulation in decidua. Immunol Today 1998; 19:142-143.
30. Chaouat G, Menu E. Maternal T cell reactivity in pregnancy? Curr Top Microbiol Immunol 1997; 222:103-126.
31. Stewart-Akers AM, Krasnow JS, DeLoia JA. Decidual leukocyte • populations in ectopic pregnancies. Fertil Steril 1997; 68:1103-1107. A comparative study between intrauterine and ectopic pregnancies supported the notion that the increases in the uterine leukocyte populations that occur in early pregnancy are driven hormonally.
32. Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y, •• Amino N. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997; 37:368-377. A cross-sectional study of 305 healthy women clarified dynamic changes in peripheral lymphocyte subsets during and after pregnancy.
33. Iwatani Y, Amino N, Kabutomori O, Kaneda T, Tanizawa O, Miyai K. Peripheral large granular lymphocytes in normal pregnant and postpartum women: decrease in late pregnancy and dynamic change in the puerperium. J Reprod Immunol 1989; 16:165-172.
34. + cells in the peripheral blood lymphocytes in the first trimester of pregnancy and up-regulation at the end of pregnancy. Am J Reprod Immunol 1997; 38:189-196. This group leads the perform research, and here clarified the changes in perforin-positive cells during pregnancy.
35. Kuhnert M, Strohmeier R, Stegmuller M, Halberstadt E. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 76:147-151.
36. Bermas BL, Hill JA. Proliferative responses to recall antigens are • associated with pregnancy outcome in women with a history of recurrent spontaneous abortion. J Clin Invest 1997; 100:1330-1334. This study demonstrated again that the suppression of T cell-mediated immunity is necessary for the maintenance of early pregnancy, and that the assessment of the immunosuppression may be useful in predicting pregnancy outcome.
37. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
38. + T cells during pregnancy.
39. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998; 840:45-50.
40. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang XJ, Pennline K, et al. •• Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J 1998; 12:189-197. This is a study to test the efficacy of the anti-inflammatory cytokine, IL-10, as an agent of protection against lipopolysaccharide-induced fetal growth restriction and fetal demise, using a new animal model of intrauterine growth restriction. IL-10, which normalizes the increases of uterine TNF-α content and nitric oxide release and the apoptosis of uterine epithelia, may be useful for the treatment.
41. Haddad EK, Duclos AJ, Antecka E, Lapp WS, Baines MG. Role of interferon-γ in the priming of decidual macrophages for nitric oxide production and early pregnancy loss. Cell Immunol 1997; 181:68-75.
42. Gorivodsky M, Zemlyak I, Orenstein H, Savion S, Fein A, Torchinsky A, Toder V. TNF-α messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss. J Immunol 1998; 160:4280-4288.
43. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-•• dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothombinase. J Immunol 1998; 160:545-549. A well-designed study using a CBA × DBA/2 mouse model with spontaneous resorption, which is attributed to NK cells, macrophages, and Th1 cytokines, demonstrated that cytokine-triggered thrombotic/ inflammatory processes in maternal uteroplacental blood vessels causes abortion.
44. Steinbone A, von Gall C, Hildenbrand R, Stutte HJ, Kaufmann M. Identification of placental cytokine-producing cells in term and preterm labor. Obstet Gynecol 1998; 91:329-335.
45. Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type I cytokines in • the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J Immunol 1998; 160:2523-2530. This is the first demonstration that placental changes of type 1 cytokines are associated with poor pregnancy outcomes in humans.
46. Gafter U, Sredni B, Segal J, Kalechman Y. Suppressed cell-mediated •• immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J Clin Immunol 1997; 17:408-419. A study of nine women with spontaneous recurrent abortion demonstrated that the alloimmunization of women clearly directs the immune system towards the humoral effector arm and simultaneously decreases cell-mediated immunity and innate resistance.
47. Hamai Y, Fujii T, Yamashita T, Hishina H, Kozuma S, Mikami Y, Taketani Y. Evidence for an elevation in serum interteukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38:89-93.
48. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
49. Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I, et al. High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 1982; 306:849-852.
50. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, •• Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339:285-291. A follow-up study of 254 women with multiple sclerosis during and after pregnancy demonstrated that in women with multiple sclerosis, the rate of relapse declines during pregnancy, especially in the third trimester, and increases during the first 3 months postpartum before returning to the prepregnancy rate.